FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncohematology, and can be used to predict the risk of an infection caused by SARS-CoV-2 with lung damage in patients with hematological malignancies. The polymorphism of the IL4 and IL10 genes in genomic DNA isolated from whole blood leukocytes is assessed. An analysis of the distribution of genotypes of the studied loci is carried out. In case of detection of combinations of genotypes of loci IL10-1082TT × IL4-590CC × IL10-819AG, IL10-1082TT × IL4-590TT × IL10-819AA, IL10-1082TT × IL4-590TT × IL10-819AG, IL10-59 × IL10-819AG, IL10-59 × IL10-819AG, IL10-1082TC × IL4-590ct × IL10-819AG, IL10-1082TC × IL4-590TT × IL10-819AA, IL10-1082ts × IL4-590TT × IL10 819AG, IL10-1082CC × IL4-590TT × IL10-819AA, IL10-1082CC × IL4-590TT × IL10-819AG a high risk of lung injury with COVID-19 is predicted.
EFFECT: method provides effective prediction of the risk of developing COVID-19 with lung damage in patients with hematological malignancies by analyzing the distribution of the genotypes of the IL4 and IL10 loci.
1 cl, 3 dwg, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING THE RISK OF SEVERE ACNE BASED ON DETERMINING THE EXPRESSION OF IL1RN AND IL10 GENES | 2020 |
|
RU2739890C1 |
METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2794035C1 |
METHOD FOR DETECTION OF PRIMARY REFRACTORY FORM OF MULTIPLE MYELOMA AT THE DISEASE ONSET | 2020 |
|
RU2749612C1 |
METHOD FOR PREDICTING THE RISK OF SEVERE COVID-19 IN A PATIENT | 2022 |
|
RU2791487C1 |
METHOD FOR PREDICTION OF SEVERITY OF INFECTION CAUSED BY SARS-CoV-2 IN YOUNG PEOPLE IN INITIAL PERIOD OF DISEASE | 2024 |
|
RU2821547C1 |
BROADLY NEUTRALIZING ANTIBODY AGAINST SARS-CoV-2 | 2022 |
|
RU2810476C1 |
METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME FOR PATIENTS IN CHRONIC CRITICAL CONDITION DUE TO CEREBRAL ACCIDENTS COMPLICATED BY PNEUMONIA | 2024 |
|
RU2822966C1 |
METHOD FOR PREDICTION OF SELF-EXISTING COXARTHROSIS DEVELOPMENT | 2017 |
|
RU2646456C1 |
METHOD FOR ASSESSMENT OF RISK OF NECESSITY OF USE OF OXYGEN THERAPY IN COVID-19 | 2021 |
|
RU2777487C1 |
Authors
Dates
2022-11-14—Published
2022-04-12—Filed